Unlike other COMPASS family members that trimethylated H3K4, MLL3 (KMT2C) and MLL4 catalyze histone H3K4 monomethylation at the enhancer (27, 28) and are the most common mutant histone modifiers in human cancer (29). Here, KMT2C is linked to cancer.